Abstract
Purpose. To investigate the role of carrier mechanisms in: [1] the polarized transport of the bis(pivaloyloxymethyl)- [bis(POM)-] ester prodrug of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine [PMEA] and [2] the directional secretion of its metabolites.
Methods. Caco-2 monolayers were used to study the modulating effect of carriers on the transport of bis(POM)-PMEA and the efflux of intracellularly formed metabolites mono(POM)-PMEA and PMEA from the cells. The interaction of bis(POM)-PMEA and its metabolites with the efflux mechanisms present in Caco-2 monolayers was investigated by testing the effect of various concentrations of verapamil (30, 100, 300 μM) or indomethacin (10-500 μM) on transport and efflux.
Results. Polarity in transport of bis(POM)-PMEA (50 μM) across Caco-2 monolayers was noted: transport of total PMEA [=bis(POM)-PMEA, mono(POM)-PMEA and PMEA] was significantly higher in basolateral (BL) to apical (AP) direction (14.5 ± 0.4%) than transport in the opposite (AP to BL) direction (1.7 ± 0.2%). This difference was reduced in a concentration dependent way when verapamil (0−100 μM) was included in both AP and BL incubation media. After loading the cells with bis(POM)-PMEA (100 μM) for 1 hr, studies on efflux of PMEA and mono(POM)-PMEA from the Caco-2 monolayers over a 3 hr period, revealed that both metabolites were preferentially secreted towards the AP compartment. Efflux of PMEA towards AP and BL compartments amounted to 14.6 ± 1.1 % and 5.3 ± 0.4%, respectively, of the initial intracellular amount of total PMEA, while efflux of mono(POM)-PMEA towards AP and BL compartments was limited to 2.3 ± 0.1 % and 0.5 ± 0.1 %, respectively. When 10 μM indomethacin was included in the AP incubation medium, efflux of PMEA was decreased to 7.8 ± 0.3% and 3.3 ± 0.3% towards the AP and BL compartments, respectively. The decrease in efflux by indomethacin was concentration-dependent up to 100 μM. Transepithelial transport of total PMEA was also reduced in the presence of 30 μM indomethacin, as reflected in smaller concentrations of PMEA and mono(POM)-PMEA in the acceptor compartment, irrespective of the transport direction.
Conclusions. The data obtained in this study suggest that bis(POM)-PMEA is substrate for a P-glycoprotein-like carrier mechanism in Caco-2 monolayers, while its metabolites mono(POM)-PMEA and PMEA are transported by a non-P-glycoprotein efflux protein.
Similar content being viewed by others
REFERENCES
L. Naesens, J. Balzarini, N. Bischofberger, and E. De Clercq. Antiretroviral activity and pharmacokinetics in mice of oral bis-(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine. Antimicrob. Agents Chemother. 40:22-28 (1996).
P. A. Barditch-Crovo, J. Toole, C. W. Hendrix, K. C. Cundy, D. Ebeling, H. S. Jaffe, and P. S. Lietman. Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-bis-(pivaloyloxymethyl)phosphonyl-methoxyethyl]adenine) in HIV infected patients. J. Inf. Dis. 176:406-413 (1997).
P. Artursson. Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drugs over Intestinal Absorptive (Caco-2) Cells. J. Pharm. Sci. 79:476-482 (1990).
K. L. Audus, R. L. Bartel, I. J. Hildago, and R. T. Borchardt. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm. Res. 7:435-451 (1990).
A. R. Hilgers, R. A. Conradi, and P. S. Burton. Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa. Pharm. Res. 7:902-910 (1990).
L. S. Gan, C. Eads, T. Niederer, A. Bridgers, S. Yanni, P.-H. Hsyu, F. J. Pritchard, and D. Thakker. Use of Caco-2 Cells as an in vitro intestinal absorption and metabolism model. Drug Dev. Ind. Pharm. 20:615-631 (1994).
P. Annaert, R. Kinget, L. Naesens, E. De Clercq, and P. Augustijns. Transport, uptake and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitrocell culture system of the intestinal mucosa (Caco-2). Pharm. Res. 14:492-496 (1997).
P. Annaert, G. Gosselin, A. Pompon, S. Benzaria, G. Valette, J.-L. Imbach, L. Naesens, S. Hatse, E. De Clercq, G. Van den Mooter, R. Kinget, and P. Augustijns. Comparison of the disposition of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxy-ethyl)adenine [PMEA] in Caco-2 monolayers. Pharm. Res. 15:243-249 (1998).
J. Hunter, B. H. Hirst, and N. L. Simmons. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res. 10:743-749 (1993).
D. Brouty-Boyé, D. Kolonias, C. J. Wu, N. Savaraj, and T. J. Lampidis. Relationship of multidrug resistance to Rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux. Cancer Res. 55:1663-1638 (1995).
A. Tsuji, T. Terasaki, Y. Takabatake, Y. Tenda, I. Tamai, T. Yamashima, S. Moritani, T. Tsuruo, and J. Yamashita. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51:1427-1437 (1992).
J. Hunter, M. A. Jepson, T. Tsuruo, N. L. Simmons, and B. H. Hirst. Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. J. Biol. Chem. 268:14991-14997 (1993).
H. Saitoh, and B. J. Aungst. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 12:1301-1310 (1995).
J. Karlsson, S.-M. Kuo, J. Ziemniak, and P. Artursson. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein. Br. J. Pharmacol. 110:1009-1016 (1993).
M. E. Cavet, M. West, and N. L. Simmons. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 118:1389-1396 (1996).
P. F. Augustijns, T. P. Bradshaw, L.-S. L. Gan, R. W. Hendren, and D. R. Thakker, Evidence for a polarized efflux system in Caco-2 cells capable of modulating Cyclosporin A transport. Biochem. Biophys. Res. Comm. 197:360-365 (1993).
P. S. Burton, R. A. Conradi, A. R. Hilgers, and N. F. H. Ho. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochem. Biophys. Res. Comm. 190:760-766 (1993).
C. Cordon-Cardo, J. P. O'Brien, J. Boccia, D. Casals, J. R. Bertino, and M. R. Melamed. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1277-1287 (1990).
C. N. Allen, E. S. Harpur, T. J. B. Gray, N. L. Simmons, and B. H. Hirst. Efflux of bis-carboxyethyl-carboxyfluorescein (BCECF) by a novel ATP-dependent transport mechanism in epithelial cells. Biochem. Biophys. Res. Comm. 172:262-267 (1990).
G. K. Collington, J. Hunter, C. N. Allen, N. L. Simmons, and B. H. Hirst. Polarized efflux of 2', 7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein from cultured epithelial cell monolayers. Biochem. Pharmacol. 44:417-424 (1992).
P. Augustijns, P. Annaert, P. Heylen, G. Van den Mooter, and R. Kinget. Drug absorption studies of prodrug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport. Int. J. Pharm.(accepted for publication).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Annaert, P., Van Gelder, J., Naesens, L. et al. Carrier Mechanisms Involved in the Transepithelial Transport of bis(POM)-PMEA and Its Metabolites Across Caco-2 Monolayers. Pharm Res 15, 1168–1173 (1998). https://doi.org/10.1023/A:1011923420719
Issue Date:
DOI: https://doi.org/10.1023/A:1011923420719